Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and ...
A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries ...
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
The Trump administration is taking steps to meet with pharmaceutical companies to examine pharmacy benefit managers (PBMs) ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Chief Executive David Joyner spent a lot of time on the post-earnings call with analysts defending PBMs, or what critics have called "drug middlemen." CVS is a PBM through its CVS Caremark business.
Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...